TRIAL WATCH HIV integrase inhibitor-based regimen beats market leader

被引：1
|
作者：
Crunkhorn, Sarah
机构：
来源：
NATURE REVIEWS DRUG DISCOVERY | 2012年 / 11卷 / 09期
关键词：
D O I：
10.1038/nrd3836
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：664 / 664
页数：1
相关论文
共 50 条
  • [31] Glycemic Control in Patients Living With HIV Initiated on Integrase Inhibitor-Based Three-Drug Antiretroviral Therapy
    Gerber, Anthony
    Longo, Maria
    Fischetti, Briann
    Popova, Olga
    JOURNAL OF PHARMACY TECHNOLOGY, 2024, 40 (02) : 85 - 91
  • [32] Lower Incidence of HIV-1 Blips Observed During Integrase Inhibitor-Based Combination Antiretroviral Therapy
    Dijkstra, Suzan
    Hofstra, L. Marije
    Mudrikova, Tania
    Wensing, Annemarie M. J.
    Oomen, Patrick G. A.
    Hoepelman, Andy I. M.
    van Welzen, Berend J.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2022, 89 (05) : 575 - 582
  • [33] Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing
    Nguyen, T.
    Fofana, D. B.
    Le, M. P.
    Charpentier, C.
    Peytavin, G.
    Wirden, M.
    Lambert-Niclot, S.
    Desire, N.
    Grude, M.
    Morand-Joubert, L.
    Flandre, P.
    Katlama, C.
    Descamps, D.
    Calvez, V.
    Todesco, E.
    Marcelin, A. G.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (09) : 2485 - 2492
  • [34] Considerations on the effectiveness of nevirapine in protease inhibitor-based regimen simplification
    Martinez, Esteban
    Gatell, Jose M.
    AIDS, 2007, 21 (13) : 1829 - 1830
  • [35] Similar plasma lipidomic profile in people living with HIV treated with a darunavir-based or an integrase inhibitor-based antiretroviral therapy
    Mena, Alvaro
    Clavero, Elvira
    Luis Diaz-Diaz, Jose
    Castro, Angeles
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [36] Similar plasma lipidomic profile in people living with HIV treated with a darunavir-based or an integrase inhibitor-based antiretroviral therapy
    Alvaro Mena
    Elvira Clavero
    José Luis Díaz-Díaz
    Angeles Castro
    Scientific Reports, 9
  • [37] Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohort
    Foca, Emanuele
    Calcagno, Andrea
    Calza, Stefano
    Renzetti, Stefano
    Chiesa, Annacarla
    Siano, Matteo
    De Socio, Giuseppe
    Piconi, Stefania
    Orofino, Giancarlo
    Madeddu, Giordano
    Cattelan, Anna Maria
    Nozza, Silvia
    Ferrara, Micol
    Milic, Jovana
    Celesia, Benedetto Maurizio
    Castelli, Francesco
    Guaraldi, Giovanni
    PLOS ONE, 2021, 16 (10):
  • [38] BUDGET IMPACT OF THE INTRODUCTION OF ELVITEGRAVIR/COBICISTAT/EMTRICITABINE/TENOFOVIR, THE FIRST INTEGRASE INHIBITOR-BASED SINGLE TABLET ANTIRETROVIRAL REGIMEN FOR HIV TREATMENT, TO THIRD PARTY PAYERS IN THE UNITED STATES
    Brogan, A.
    Talbird, S. E.
    Thompson, J. R.
    Kim, Y. A.
    Olson, J.
    Peterson, J.
    Piontkowsky, D.
    Pietrandoni, G.
    VALUE IN HEALTH, 2013, 16 (07) : A343 - A344
  • [39] Effects of Integrase Inhibitor-Based ART on the NLRP3 Inflammasome Among ART-Naive People With HIV
    Toribio, Mabel
    Burdo, Tricia H.
    Fulda, Evelynne S.
    Cetlin, Madeline
    Chu, Sarah M.
    Feldpausch, Meghan N.
    Robbins, Gregory K.
    Neilan, Tomas G.
    Melbourne, Kathleen
    Grinspoon, Steven K.
    Zanni, Markella, V
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (10): : 1 - 5
  • [40] Weight gain after switching to integrase inhibitor-based ART is not associated with hepatic steatosis in HIV-infected patients
    Gonzalez-Serna, A.
    Macias, J.
    Rincon, P.
    Arriaza, M. J.
    Corma-Gomez, A.
    Santos, M.
    Fernandez-Fuertes, M.
    Real, L. M.
    Pineda, J. A.
    HIV MEDICINE, 2021, 22 : 88 - 89
12345